Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

Optionable: Yes  Market Cap: 2,394 M  90-day average vol: 1,448,067

Previous close: 25.93  Open: 26.2  Bid: 25.06  Ask: 25.94
52 week range    
Last updated: Tuesday 16th April 2024
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


BEAM Income Statement

Invalid dateDec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock1 M
Basic EPS from continuing operations-4.19-5.77-4.13-1.72
Basic EPS total-4.19-5.77-4.13-1.72
Basic weighted shares outstanding47 M64 M70 M77 M
Depreciation5 M7 M14 M20 M
DepreciationAndAmortization5 M7 M14 M20 M
Diluted EPS total-4.19-5.77-4.13-1.72
Diluted normalized net income/share-5.77-4.13-1.72
Diluted weighted shares outstanding64 M70 M77 M
Earnings from equity interest-25 M
EarningsFromEquityInterestNetOfTax-25 M
GainOnSaleOfSecurity-63 M17 M44 M-11 M
GeneralAndAdministrativeExpense30 M57 M88 M117 M
Gross operating profit24000.052 M61 M378 M
Income before tax-195 M-371 M-260 M-131 M
Income restructuring and M&A6 M
Income taxes3 M1 M
MiscOtherSpecialCharges1 M5 M34 M56 M
Net income from total operations-195 M-371 M-289 M-133 M
NetIncomeCommonStockholders-196 M-371 M-289 M-133 M
NetIncomeContinuousOperations-195 M-371 M-289 M-133 M
Normalized income-97 M
Operating income-133 M-392 M-338 M-176 M
Operating income before depreciation (EBITDA)-190 M-363 M-246 M-111 M
OperatingExpense133 M444 M399 M554 M
Other income net62 M-22 M-53 M-45 M
OtherGandA30 M57 M88 M117 M
OtherOperatingExpenses9 M21 M23 M37 M
OtherunderPreferredStockDividend1 M
PreferredStockDividends1 M
Research & development expense103 M387 M312 M437 M
ResearchExpense103 M387 M312 M437 M
RestructringAndMnAIncome6 M
Selling Gen & administrative expense30 M57 M88 M117 M
Special income/charges-6 M
Total Income available for interest expense (EBIT)-195 M-371 M-260 M-131 M
Total common shares outstanding62 M69 M72 M82 M
Total net income-195 M-371 M-289 M-133 M
Total ordinary shares82 M82 M82 M82 M
Total revenues24000.052 M61 M378 M
TotalExpenses133 M444 M399 M554 M
TotalRevenue24000.052 M61 M378 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University